The psychosocial impact of the COVID-19 pandemic on MGUS, smouldering and active myeloma patients: findings from an international survey

Stephen Quinn; Lesley Anderson; Lynne Lohfeld; Charlene M. McShane

doi:10.1111/bjh.17427

The psychosocial impact of the COVID-19 pandemic on MGUS, smouldering and active myeloma patients: findings from an international survey

Stephen Quinn, Lesley Anderson, Lynne Lohfeld, Charlene M. McShane

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

2 Downloads (Pure)

Abstract

Early in the COVID‐19 pandemic, the UK National Health Service (NHS) identified multiple myeloma (MM) patients as a “clinically extremely vulnerable” population1. In contrast, the clinical significance of COVID‐19 to MM precursors, monoclonal gammopathy of undermined significance (MGUS)2 and smouldering multiple myeloma (SMM)3, remains unknown.

Here for the first time we summarise the impact of the COVID‐19 pandemic on 274 MM spectrum individuals (66 MGUS, 33 SMM, 175 MM) who participated in the IMPaCCT (Investigating the impact of COVID‐19 on caregivers and patients) study. The first wave of this online international longitudinal study took place between 24 April‐14 July 2020.

Original language	English
Pages (from-to)	294-297
Number of pages	4
Journal	British Journal of Haematology
Volume	194
Issue number	2
Early online date	21 Jun 2021
DOIs	https://doi.org/10.1111/bjh.17427
Publication status	Published - Jul 2021

Keywords

COVID-19
psychosocial needs
myeloma
monoclonal gammopathy of undetermined significance (MGUS)
smouldering myeloma

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/bjh.17427Licence: Unspecified

Quinn_etal_psychological_impact_AAM
This is the peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions
Accepted author manuscript, 67.9 KBLicence: Unspecified

Cite this

@article{b77474d40f4946549f94be6d2aa5b334,

title = "The psychosocial impact of the COVID-19 pandemic on MGUS, smouldering and active myeloma patients: findings from an international survey",

abstract = "Early in the COVID‐19 pandemic, the UK National Health Service (NHS) identified multiple myeloma (MM) patients as a “clinically extremely vulnerable” population1. In contrast, the clinical significance of COVID‐19 to MM precursors, monoclonal gammopathy of undermined significance (MGUS)2 and smouldering multiple myeloma (SMM)3, remains unknown.Here for the first time we summarise the impact of the COVID‐19 pandemic on 274 MM spectrum individuals (66 MGUS, 33 SMM, 175 MM) who participated in the IMPaCCT (Investigating the impact of COVID‐19 on caregivers and patients) study. The first wave of this online international longitudinal study took place between 24 April‐14 July 2020.",

keywords = "COVID-19, psychosocial needs, myeloma, monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma",

author = "Stephen Quinn and Lesley Anderson and Lynne Lohfeld and McShane, {Charlene M.}",

note = "Acknowledgements: The study team would like to thank the participants for taking the time to complete this survey. The authors would also like to acknowledge the contributions of the wider IMPaCCT study team members in the initial design of the study. The named authors take sole responsibility for the analysis and interpretation presented within this paper. Research funding Northern Ireland Department for the Economy",

year = "2021",

month = jul,

doi = "10.1111/bjh.17427",

language = "English",

volume = "194",

pages = "294--297",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell ",

number = "2",

}

TY - JOUR

T1 - The psychosocial impact of the COVID-19 pandemic on MGUS, smouldering and active myeloma patients

T2 - findings from an international survey

AU - Quinn, Stephen

AU - Anderson, Lesley

AU - Lohfeld, Lynne

AU - McShane, Charlene M.

N1 - Acknowledgements: The study team would like to thank the participants for taking the time to complete this survey. The authors would also like to acknowledge the contributions of the wider IMPaCCT study team members in the initial design of the study. The named authors take sole responsibility for the analysis and interpretation presented within this paper. Research funding Northern Ireland Department for the Economy

PY - 2021/7

Y1 - 2021/7

N2 - Early in the COVID‐19 pandemic, the UK National Health Service (NHS) identified multiple myeloma (MM) patients as a “clinically extremely vulnerable” population1. In contrast, the clinical significance of COVID‐19 to MM precursors, monoclonal gammopathy of undermined significance (MGUS)2 and smouldering multiple myeloma (SMM)3, remains unknown.Here for the first time we summarise the impact of the COVID‐19 pandemic on 274 MM spectrum individuals (66 MGUS, 33 SMM, 175 MM) who participated in the IMPaCCT (Investigating the impact of COVID‐19 on caregivers and patients) study. The first wave of this online international longitudinal study took place between 24 April‐14 July 2020.

AB - Early in the COVID‐19 pandemic, the UK National Health Service (NHS) identified multiple myeloma (MM) patients as a “clinically extremely vulnerable” population1. In contrast, the clinical significance of COVID‐19 to MM precursors, monoclonal gammopathy of undermined significance (MGUS)2 and smouldering multiple myeloma (SMM)3, remains unknown.Here for the first time we summarise the impact of the COVID‐19 pandemic on 274 MM spectrum individuals (66 MGUS, 33 SMM, 175 MM) who participated in the IMPaCCT (Investigating the impact of COVID‐19 on caregivers and patients) study. The first wave of this online international longitudinal study took place between 24 April‐14 July 2020.

KW - COVID-19

KW - psychosocial needs

KW - myeloma

KW - monoclonal gammopathy of undetermined significance (MGUS)

KW - smouldering myeloma

U2 - 10.1111/bjh.17427

DO - 10.1111/bjh.17427

M3 - Letter

C2 - 33763875

VL - 194

SP - 294

EP - 297

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -

The psychosocial impact of the COVID-19 pandemic on MGUS, smouldering and active myeloma patients: findings from an international survey

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this